Baicalein Decreases Hydrogen Peroxide-Induced Damage to NG108-15 Cells via Upregulation of Nrf2

Journal of Cellular Physiology

Volumn 230, Issue 8, 2015, Pages 1840-1851

  Yeh, Chao Hung ^b   Ma, Kuo Hsing ^a   Liu, Pei Shan ^c   Kuo, Jung Kuei ^a   Chueh, Sheau Huei ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c SOOCHOW UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ACETYLCYSTEINE; ARACHIDONATE 12 LIPOXYGENASE; BAICALEIN; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; FLAVANONE DERIVATIVE; OXIDIZING AGENT; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; IMMUNOBLOTTING; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL LINE; FLAVANONES; FLUORESCENT ANTIBODY TECHNIQUE; HYDROGEN PEROXIDE; IMMUNOBLOTTING; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NF-E2-RELATED FACTOR 2; OXIDANTS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

EID: 84928384810     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24900     Document Type: Article

References (31)

1. 40 by protein kinase C in response to antioxidant leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem 278:44675-44682.
2. Bryan HK, Olayanju A, Goldring CE, Park BK. 2013. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol 85:705-717.
3. Cathcart R, Schwiers E, Ames BN. 1983. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem 134:111-116.
4. Chao JI, Su WC, Liu HF. 2007. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and surviving associated with opposite role of p38 mitogen-activated protein kinase and AKT. Mol Cancer Ther 6:3039-3048.
5. Cheng YH, Li LA, Lin P, Cheng LC, Hung CH, Chang NW, Lin C. 2012. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation. Toxicol Appl Pharmacol 263:360-367.
6. Chi DS, Lin TC, Hall K, Ha T, Li C, Wu ZD, Soike T, Krishnaswamy G. 2012. Enhanced effects of cigarette smoke extract on inflammatory cytokine expression in il-1beta-activated human mast cells were inhibited by baicalein via regulation of the NFκB pathway. Clin Mol Allergy 10:3-14.
7. Chin TY, Kao CH, Wang HY, Huang WP, Ma KH, Chueh SH. 2010. Inhibition of the mammalian target of rapamycin promotes cyclic AMP-induced differentiation of NG108-15. cells. Autophagy 6:1139-1156.
8. Deschamps JD, Kenyou VA, Holman TR. 2006. Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. Bioorg Med Chem 14:4295-4301.
9. Firuzi O, Miri R, Tavakkoli M, Saso L. 2011. Antioxidant therapy: Current status and future prospects. Curr Med Chem 18:3871-3888.
10. Gao Z, Huang K, Yang X, Xu H. 1999. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of scutellaria baicalensis georgi. Biochim Biophys Acta 1472:643-650.
11. Kim KC, Lee IK, Kang KA, Kim HS, Kang SS, Hyun JW. 2012. Baicalein (5, 6, 7-trihydroxyflavone) reduces oxidative stress-induced DNA damage by upregulating the DNA repair system. Cell Biol Toxicol 28:421-433.
12. Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S. 2013. The complex interplay of iron metabolism, reactive oxygen and reactive nitrogen species: Insights into the potential of different iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med 65:1174-1194.
13. Li CY, Chin TY, Chueh SH. 2004. Rat cerebellar granule cells are protected from glutamate-induced excitotoxicity by S-nitrosoglutathione but not glutathione. Am J Physiol Cell Physiol 286:C893-C904.
14. Lin KC, Liu PS, Peng PY, Chueh SH. 2012. Acute phorbol ester treatment inhibits thapsigargin-induced cell death in porcine aortic smooth muscle cells. Eur J Pharmacol 686:8-15.
15. 2-induced apoptosis via inhibiting mitochondria-dependent caspase activation and the p38 MAPK pathway. Free Radic Biol Med 53:183-193.
16. Liu C, Wu J, Xu K, Cai F, Gu J, Ma L, Chen J. 2010. Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway. J Neurochem 112:1500-1512.
17. Ma GZ, Liu CH, Wei B, Qiao J, Lu T, Wei HC, Chen HD, He CD. 2013. Baicalein inhibits DMBA/TPA-induced skin tumorigenesis in mice by modulating proliferation, apoptosis, and inflammation. Inflammation 36:457-467.
18. Mascayano C, Espinosa V, Sepúlveda-Boza S, Hoobler EK, Perry S. 2013. In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases. Chem Biol Drug Des 82:317-325.
19. McGee R, Simpson P, Christian C, Mata M, Nelson P, Nirenberg M. 1978. Regulation of acetylcholine release from neuroblastoma x glioma hybrid cells. Proc Natl Acad Sci USA 75:1314-1318.
20. Mu X, He G, Cheng Y, Li X, Xu B, Du G. 2009. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol Biochem Behav 92:642-648.
21. Nakata K, Tanaka Y, Nakano T, Adachi T, Tanaka H, Kaminuma T, Ishikawa T. 2006. Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing system. Drug Metab Pharmacokinet 21:437-457.
22. Nelson P, Christian C, Nirenberg M. 1976. Synapse formation between clonal neuroblastoma x glioma hybrid cells and striated muscle cells. Proc Natl Acad Sci USA 73:123-127.
23. Pallast S, Arai K, Pekcec A, Yigitkanli K, Yu Z, Wang X, Lo EH, van Leyen K. 2010. Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12/15-lipoxygenase-dependent organelle damage pathway. J Cereb Blood Flow Metab 30:1157-1167.
24. Qin S, Chen J, Tanigawa S, Hou DX. 2012. Gene expression profiling and pathway network analysis of hepatic metabolic enzymes targeted by baicalein. J Ethnopharmacol 140:131-140.
25. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F. 1995. Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Radic Biol Med 19:481-486.
26. Shelton P, Jaiswal AK. 2013. The transcription factor NF-E2-related factor 2 (Nrf2): A protooncogene. FASEB J 27:414-423.
27. Slemmer JE, Shacka JJ, Sweeney MI, Weber JT. 2008. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem 15:404-414.
28. Xu C, Li CY, Kong AN. 2005. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249-268.
29. Xu YW, Sun L, Liang H, Sun GM, Cheng Y. 2010. 12/15-lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia/reperfusion. Brain Res 1307:149-157.
30. Zhang M, An C, Gao Y, Leak RK, Chen J, Zhang F. 2013. Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog Neurobiol 100:30-47.
31. Zhang Z, Cui W, Li G, Yuan S, Xu D, Hoi MP, Lin Z, Dou J, Han Y, Lee SM. 2012. Baicalein protect against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCalpha and PI3K/Akt signaling pathways. J Agric Food Chem 60:8171-8182.